phthivazide has been researched along with 3-nitrobenzaldehyde isonicotinoylhydrazone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajorath, J; Channar, PA; Hassan, S; Iqbal, J; Lecka, J; Nisa, ZU; Saeed, A; Sévigny, J; Shah, SJ | 1 |
| Farias, AB; Henriques, RR; Junior, MAAL; Nogueira, TLDC; Quimas, JVF; Romeiro, NC; Santos, DC; Silva, LLD; Souza, ALF | 1 |
2 other study(ies) available for phthivazide and 3-nitrobenzaldehyde isonicotinoylhydrazone
| Article | Year |
|---|---|
Isonicotinohydrazones as inhibitors of alkaline phosphatase and ecto-5'-nucleotidase.
Topics: 5'-Nucleotidase; Alkaline Phosphatase; Animals; Chemistry Techniques, Synthetic; Drug Evaluation, Preclinical; Enzyme Inhibitors; GPI-Linked Proteins; Humans; Isoniazid; Models, Molecular; Molecular Docking Simulation; Protein Conformation; Rats; Structure-Activity Relationship | 2017 |
Acylhydrazones as isoniazid derivatives with multi-target profiles for the treatment of Alzheimer's disease: Radical scavenging, myeloperoxidase/acetylcholinesterase inhibition and biometal chelation.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antioxidants; Biphenyl Compounds; Chelating Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Electrophorus; Humans; Hydrazones; Molecular Docking Simulation; Molecular Structure; Neuroprotective Agents; Peroxidase; Picrates; Structure-Activity Relationship | 2020 |